Business
VIMAB: Major loss in 2024, but large battery orders and divestment set stage for 2025 turnaround
VIMAB: Major loss in 2024, but large battery orders and divestment set stage for 2025 turnaround
About this update from Vimab Group Ab
Vimab Group reported a 5% sales decline and a significant net loss in 2024, driven by goodwill write-downs, but expects a strong rebound in 2025 from major battery system orders and the divestment of Vimab AB. Equity ratio fell sharply, and financing needs remain high. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.